MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
Japan's Interest Rate Hike Signal Triggers "Bloodletting" Worries in U.S. Markets, Fed's Rate Cut Prospect May Change
Lily Liu Criticizes The New York Times for Biased Reporting on Innovation and AI
BlackRock: Tokenization is evolving at a pace comparable to the early Internet, poised for significant growth
Whale "pension-usdt.eth" yesterday saw its ETH long position fall below the average price, with a position size reaching $56 million.
Dark Pool DEX HumidiFi to Launch ICO, Leading in Trading Volume Among Solana Ecosystem DEXs
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]